Cutler Group LP Legend Biotech Corp Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Cutler Group LP holds 1,900 shares of LEGN stock, worth $76,019. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,900
Previous 10,900
82.57%
Holding current value
$76,019
Previous $4,000
2550.0%
% of portfolio
0.03%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$438 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$239 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$215 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$105 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$95.5 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.7B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...